6/14/2010

Aspirin Linked to Reduced Risk of Breast Cancer Metastasis and Death

Taking aspirin regularly may decrease risk of death from breast cancer and risk of breast cancer metastasis for women who have had early-stage breast cancer. Read more ...

5/21/2010

Shorter Course of Radiation Possible for Some Breast Cancers

Three weeks of higher dose radiation worked as well as the standard-dose, five-week schedule after a lumpectomy for invasive, lymph node-negative disease, study shows. Read more ...

4/23/2010

Leading Provider Groups Set Guidelines for Hormone Receptor Testing

New standards for ER, PR tests in breast cancer have been released by American Society of Clinical Oncology and College of American Pathologists. Read more ...

4/8/2010

Chemotherapy Combination Less Toxic to Heart

Herceptin-based treatments without anthracyclines caused fewer cases of heart failure than treatments containing anthracyclines, study at San Antonio Symposium shows. Read more ...

3/17/2010

The Health Bill: How It Could Impact You

Increased access to treatment and follow-up care, protection of coverage in case of job change or loss, ensuring coverage despite pre-existing conditions and increasing quality and quantity of life for young women are among the ways the healthcare overhaul bill may impact people with a history of breast cancer. Read more ...

2/5/2010

Body Mass Index Impacts Breast Cancer Prognosis

A body mass index of more than 25 (being overweight or obese) is related to metastatic recurrence and poorer survival rates in women who have had breast cancer, according to results released at the San Antonio Breast Cancer Symposium. Read more ...

2/2/2010

Herceptin and Tykerb News from San Antonio

Lapatinib plus trastuzumab was more effective than lapatinib alone for women with HER2 positive advanced breast cancer that progressed on trastuzumab, San Antonio study shows. Read more ...

1/15/2010

New Breast Cancer Guidelines Released

Prophylactic mastectomy is recommended only for women at high risk for developing breast cancer, according to new NCCN guidelines. Read more ...

12/15/2009

Questions to Ask About Clinical Trials

This list will help you talk with your doctor or nurse about whether being part of a breast cancer treatment research study is right for you: Read more ...

12/12/2009

New Treatment Paradigms for Breast Cancer: Managing the Flow of New Data

Four studies presented at San Antonio looked at existing therapies being tested in unique ways as the landscape of acceptable treatment and management of breast cancer continues to shift. Read more ...

12/11/2009

Medicines in the Pipeline: What’s Emerging in Late-Stage Trials

The second press conference held at the San Antonio Breast Cancer Symposium featured four studies that looked at emerging therapies in the treatment of breast cancer. Read more ...

12/11/2009

MRI Detects Breast Cancer at Earlier Stage

Magnetic resonance imaging (MRI) coupled with mammography detects almost all cancers at an early stage, reducing the incidence of advanced breast cancer in high-risk women, according to a study presented at the San Antonio Breast Cancer Symposium. Read more ...

12/11/2009

How Lifestyle Factors Can Affect Breast Cancer

A further connection between lifestyle factors and breast cancer is revealed in two new studies presented during the San Antonio Breast Cancer Symposium. Read more ...

12/10/2009

Breaking News from the San Antonio Breast Cancer Symposium

LBBC is happy to attend the San Antonio Breast Cancer Symposium (SABCS) and bring you the latest information coming out of this meeting. Read more ...

11/19/2009

Secretary Sebelius Statement on New Breast Cancer Recommendations

HHS Secretary Kathleen Sebelius issued a statement yesterday on new breast cancer screening recommendations from the U.S. Preventive Services Task Force. Read more ...

11/18/2009

Living Beyond Breast Cancer Statement on New Mammography Guidelines

On November 16, 2009, The United States Preventive Services Task Force (USPSTF) announced that it is changing its guidelines for mammography and no longer recommends routine screening for women between the ages of 40 and 49 who are at average risk for developing breast cancer. Read more ...

11/4/2009

Guidelines Released for Managing Metastatic Breast Cancer

Single-agent chemotherapy is recommended over combination for metastatic disease, says the European School of Oncology’s Metastatic Breast Cancer Task Force. Read more ...